Univariate model | Multivariable model (stepwise) | |||||
---|---|---|---|---|---|---|
Odds Ratios | 95% CI | p-value | Odds Ratios | 95% CI | p-value | |
Male | 1.42 | 0.67-3.01 | 0.36 | |||
Age ≥ 65 years old | 0.54 | 0.21-1.38 | 0.21 | |||
Albumin < 35 g/L | 11.73 | 2.66-51.78 | 0.01 | 8.24 | 1.75-38.81 | 0.008 |
LDH > ULN | 1.81 | 0.86-3.79 | 0.12 | |||
Metastatic sites > 2 | 3.01 | 1.42-6.38 | 0.01 | 2.57 | 1.15-5.72 | 0.02 |
ECOG Performance Status > 0 | 7.40 | 2.51-21.81 | 0.01 | 6.23 | 2.06-18.83 | 0.001 |
Hemoglobin < 12 g/dL | 2.47 | 1.167-5.21 | 0.02 | |||
WBC > 10.5 × 10 9 /L | 2.59 | 1.04-6.44 | 0.04 | |||
Platelets > 400 × 10 9 /L | 0.97 | 0.31-2.98 | 0.95 | |||
Lymphocytes < 0.7 × 10 9 /L | 2.21 | 0.94-5.23 | 0.07 | |||
Lung metastases | 2.04 | 0.92-4.51 | 0.08 | |||
Liver metastases | 2.04 | 0.94-4.43 | 0.07 | |||
Bone metastases | 1.41 | 0.57-3.53 | 0.46 | |||
Brain metastases | 6.22 | 0.38-101.94 | 0.22 | |||
Lymph node metastases | 2.16 | 1.02-4.54 | 0.04 | |||
Peritoneal metastases | 0.76 | 0.28-2.10 | 0.60 | |||
Prior treatments ≥ 3 | 0.76 | 0.35-1.64 | 0.48 |